ABCG5 and fatty liver disease: Several human and animal studies have linked ABCG5/G8 variants and expression with cardiometabolic traits, such as insulin sensitivity, glycemic control, blood pressure status, and fatty liver disease [23,24,25,26,27,28,29,30].